Latest Investor Day News

EBOS Group Limited reported solid FY25 results with 12% revenue growth and strategic acquisitions, setting sights on continued expansion and operational efficiency in FY26.

EBOS Group Limited reported a steady FY25 with 12% revenue growth and EBITDA in line with guidance, driven by strong healthcare and animal care segments. The company signals confidence with maintained dividends and a positive FY26 outlook.

Genesis Energy reported a robust FY25 with a 14% rise in normalised EBITDAF and a 29% jump in net profit, driven by strategic portfolio flexibility amid volatile energy markets. The company accelerated its Gen35 strategy, including key renewable projects and long-term capacity contracts to bolster New Zealand’s energy security.

Heartland Group Holdings Limited reported an underlying NPAT of NZD 46.9 million for FY2025, meeting guidance, while setting ambitious growth and efficiency targets for FY2026.

ASX Limited reported a robust FY25 with revenue and underlying profit growth, while navigating regulatory scrutiny following a major settlement incident. The company advances its technology transformation and sustainability agenda as it seeks to rebuild trust and deliver shareholder value.

WAM Capital Limited’s July 2025 update reveals a robust net tangible asset position and a healthy interim dividend, underpinned by strong performances from key holdings ALS and HUB24.

Fletcher Building unveiled a comprehensive strategic review and FY25 outlook at its Investor Day, highlighting a focus on manufacturing and distribution alongside significant restructuring costs. The company targets a leaner operation with disciplined capital management and a net debt goal of NZD 400m to 900m.

Aurelia Metals has unveiled a robust growth strategy targeting around 40,000 tonnes of copper equivalent production by fiscal 2028, backed by a strong balance sheet and multiple development projects. The company is advancing key operations in the Cobar region while emphasizing operational discipline and sustainability.

KMD Brands reports mixed sales across its portfolio with a notable rebound in Kathmandu’s direct-to-consumer sales and robust online growth, while managing tariff uncertainties and margin pressures.

Telix Pharmaceuticals showcased its global theranostic radiopharmaceutical portfolio, highlighting FDA approvals, clinical progress, and a robust commercial expansion plan at its 2025 Investor Day.

Fletcher Building has confirmed it is fielding inquiries from potential buyers following its strategic review announcement, though no sales decisions have been made. Investors await clarity at the upcoming Investor Day.

Judo Capital Holdings Limited reaffirmed its FY25 guidance at its 2025 Investor Day, highlighting strong lending growth, a maturing technology platform, and a focused strategy to optimize its SME banking model.